ITEMS IN AFP WITH KEYWORD:
Coronary Artery Disease/Coronary Heart Disease
Jun 15, 2019 Issue
Depression After ACS Events: AAFP Releases Updated Guidelines [Practice Guidelines]
The American Academy of Family Physicians has released a guideline focusing on depression in adults within three months of an ACS event (unstable angina or myocardial infarction). The guideline is based on a systematic review of randomized controlled trials and observational studies and covers screening and treatment.
The purpose of this guideline is to provide recommendations that are relevant to primary care for the screening and treatment of depression in patients following an acute coronary syndrome (ACS) event.
Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.
Using the INTERCHEST chest pain decision rule to decide next steps when a patient presents to a primary care physician with chest pain.
In this study, after five years of treatment, patients at a moderate risk of heart disease who took low-dose aspirin did not show a decrease in coronary events and all-cause mortality and had slightly more gastrointestinal bleeding.
In this retrospective study, statin treatment in patients 75 years or older without preexisting CVD did not change the likelihood of developing CVD or reduce any-cause mortality. However, patients 75 to 84 years of age with diabetes mellitus benefitted from treatment. These results support the results from the ALLHAT study.
Dec 15, 2018 Issue
Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment with the Ankle-Brachial Index: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults.
Dec 1, 2018 Issue
Early Invasive Management of Acute Coronary Syndromes [Medicine by the Numbers]
Does early invasive management help patients with unstable angina or acute non–ST-segment elevation myocardial infarction (NSTEMI) in reducing occurence of death, myocardial infarction, angina symptoms, and rehospitalization at six- to 12-month follow-up? Find out.
This is the first of a new collaboration between AFP and the Lown Institute. This new feature promotes a vision of delivering heath care that is based on the evidence, balanced in its approach, and focused on the patient.
The best test to diagnose ACS is a risk score based on a clinical prediction rule such as the HEART (history, electrocardiography, age, risk factors, troponin level) or TIMI (Thrombolysis in Myocardial Infarction) risk score, which have positive likelihood ratios (LR+'s) of 13 and 6.8, respectively.